SCHEMBL17656205

SCHEMBL17656205

CC(C)(O)C(C)(C)OBc1ccc2c3c(ccc2c1)-c1ccc(B2OC(C)(C)C(C)(C)O2)cc1CO3

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.30
TDO2 P48775 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19339375 0.87
SCHEMBL21323908 0.82 LPL (0.35) IDO1TDO2
SCHEMBL204352 0.82 LPL (0.38) IDO1TDO2
SCHEMBL27115109 0.81 FFAR1 (0.33)
SCHEMBL12103836 0.80 LPL (0.41) IDO1TDO2
SCHEMBL12103831 0.79 LPL (0.40) IDO1TDO2
SCHEMBL21323907 0.78 PRMT5 (0.36) IDO1TDO2
SCHEMBL18721600 0.74 LIPG (0.41)
SCHEMBL18535936 0.74 PRMT5 (0.33) IDO1TDO2
SCHEMBL15600766 0.74 CA1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3002281-A1 ANTIVIRAL COMPOUNDS Gilead Pharmasset LLC (US) 2016-04-06 EP disclosed